141 related articles for article (PubMed ID: 25341694)
1. Tyms double (2R) and triple repeat (3R) confers risk for human oral squamous cell carcinoma.
Bezerra AM; Sant'Ana TA; Gomes AV; de Lacerda Vidal AK; Muniz MT
Mol Biol Rep; 2014 Dec; 41(12):7737-42. PubMed ID: 25341694
[TBL] [Abstract][Full Text] [Related]
2. Association study of the common polymorphisms in the folate-methionine pathway with retinoblastoma.
Soleimani E; Saliminejad K; Akbari MT; Kamali K; Ahani A
Ophthalmic Genet; 2016 Dec; 37(4):384-387. PubMed ID: 26914443
[TBL] [Abstract][Full Text] [Related]
3. Gene Polymorphisms Involved in Folate Metabolism and DNA Methylation with the Risk of Head and Neck Cancer.
De Castro TB; Rodrigues-Fleming GH; Oliveira-Cucolo JG; Silva JNGD; Silva FP; Raposo LS; Maniglia JV; Pavarino EC; Batista Arantes LMR; Galbiatti-Dias ALS; Maria Goloni Bertollo E
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3751-3759. PubMed ID: 33369477
[TBL] [Abstract][Full Text] [Related]
4. The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
Oosterom N; Berrevoets M; den Hoed MAH; Zolk O; Hoerning S; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
Pharmacogenet Genomics; 2018 Oct; 28(10):223-229. PubMed ID: 30222710
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms in oral squamous cell carcinoma in south-east Iran.
Miri-Moghaddam E; Saravani S; Garme Y; Khosravi A; Bazi A; Motazedian J
J Oral Pathol Med; 2016 Feb; 45(2):96-100. PubMed ID: 26218632
[TBL] [Abstract][Full Text] [Related]
6. Interactions of 5'-UTR thymidylate synthase polymorphism with 677C → T methylene tetrahydrofolate reductase and 66A → G methyltetrahydrofolate homocysteine methyl-transferase reductase polymorphisms determine susceptibility to coronary artery disease.
Vijaya Lakshmi SV; Naushad SM; Rupasree Y; Seshagiri Rao D; Kutala VK
J Atheroscler Thromb; 2011; 18(1):56-64. PubMed ID: 20962453
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in methylenetetrahydrofolate reductase and cystathionine beta-synthase in oral cancer - a case-control study in southeastern Brazilians.
Barbosa A; Dos Santos M; de Podestá JR; Gouvêa SA; Von Zeidler SV; Louro ID; Cordeiro-Silva Mde F
Braz J Otorhinolaryngol; 2016; 82(5):558-66. PubMed ID: 26749456
[TBL] [Abstract][Full Text] [Related]
8. The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence.
Cavic M; Krivokuca A; Spasic J; Brotto K; Malisic E; Radosavljevic D; Radulovic S; Jankovic R
J BUON; 2014; 19(4):1024-8. PubMed ID: 25536611
[TBL] [Abstract][Full Text] [Related]
9. The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects.
Brown KS; Kluijtmans LA; Young IS; McNulty H; Mitchell LE; Yarnell JW; Woodside JV; Boreham CA; McMaster D; Murray L; Strain JJ; Whitehead AS
Hum Genet; 2004 Jan; 114(2):182-5. PubMed ID: 14586640
[TBL] [Abstract][Full Text] [Related]
10. Retrospective case-control study of correlation between MTHFR gene and OSCC risk in North India.
Naqvi H; Ahmad MK; Hussain SR; Gupta S; Waseem M; Mahdi AA
Clin Oral Investig; 2017 Jul; 21(6):1929-1934. PubMed ID: 27774577
[TBL] [Abstract][Full Text] [Related]
11. Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population.
Wang LD; Guo RF; Fan ZM; He X; Gao SS; Guo HQ; Matsuo K; Yin LM; Li JL
Dis Esophagus; 2005; 18(3):177-84. PubMed ID: 16045580
[TBL] [Abstract][Full Text] [Related]
12. The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis.
Lopomo A; Ricciardi R; De Rosa A; Guida M; Maestri M; Lucchi M; Melfi F; Mussi A; Migliore L; Coppedè F
Gene; 2018 Feb; 642():376-380. PubMed ID: 29162511
[TBL] [Abstract][Full Text] [Related]
13. Influence of MTHFR Genetic Background on p16 and MGMT Methylation in Oral Squamous Cell Cancer.
Ferlazzo N; Currò M; Zinellu A; Caccamo D; Isola G; Ventura V; Carru C; Matarese G; Ientile R
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353639
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.
Takehara A; Kawakami K; Ohta N; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2005; 25(6C):4455-61. PubMed ID: 16334126
[TBL] [Abstract][Full Text] [Related]
15. The association between MTHFR gene polymorphisms (C677T, A1298C) and oral squamous cell carcinoma: A systematic review and meta-analysis.
Ge W; Jiao Y; Chang L
PLoS One; 2018; 13(8):e0202959. PubMed ID: 30142181
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase gene (TYMS) polymorphisms in sporadic and hereditary breast cancer.
da Silva Nogueira J; de Lima Marson FA; Sílvia Bertuzzo C
BMC Res Notes; 2012 Dec; 5():676. PubMed ID: 23217244
[TBL] [Abstract][Full Text] [Related]
17. Influence of polymorphisms in MTHFR 677 C→T, TYMS 3R→2R and MTR 2756 A→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC.
Cui LH; Yu Z; Zhang TT; Shin MH; Kim HN; Choi JS
Pharmacogenomics; 2011 Jun; 12(6):797-808. PubMed ID: 21605004
[TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients.
Kucharczyk T; Krawczyk P; Powrózek T; Kowalski DM; Ramlau R; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Krzakowski M; Milanowski J
Pathol Oncol Res; 2016 Jan; 22(1):49-56. PubMed ID: 26277606
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
[TBL] [Abstract][Full Text] [Related]
20. Genetic Markers of Therapeutic Efficacy of Methotrexate in Patients with Psoriasis.
Voron'ko OE; Baskaev KK; Sobolev VV; Denisova EV; Korsunskaya IM
Bull Exp Biol Med; 2022 Feb; 172(4):460-463. PubMed ID: 35175470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
